Adagio Medical Holdings stockholders approved a proposal allowing the Board of Directors to effect a reverse stock split at a ratio between 1-for-10 and 1-for-500. The measure passed with 13,762,886 votes in favor against 819,231 opposed, representing 53.14% of outstanding shares present or represented by proxy. The specific split ratio will be determined solely by the Board at its discretion. Adagio Medical Holdings develops and commercializes medical devices for urology.
